Back
Entrada Therapeutics Stock Predictions
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55
TRDA
Entrada Therapeutics
Last Price:
16.45
Seasonality Move:
6.92%
7 Day Trial
ALL ACCESS PASS
$
7
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Entrada Therapeutics Stock Forecast
- Over the next 52 weeks, Entrada Therapeutics has on average historically fallen by 1.7% based on the past 2 years of stock performance.
- Entrada Therapeutics has fallen lower in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Entrada Therapeutics Stock Undervalued?
The current Entrada Therapeutics [TRDA] share price is $16.44. The Score for TRDA is 55, which is 10% above its historic median score of 50, and infers lower risk than normal. - TRDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Entrada Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Entrada Therapeutics has on average historically fallen by 1.7% based on the past 2 years of stock performance.
Entrada Therapeutics Stock Rating
Buy
55
Entrada Therapeutics (TRDA)
is a Buy
Is Entrada Therapeutics overpriced?
- Entrada Therapeutics has fallen lower in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Entrada Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
entradatx.com
52-Week Data
52-Week High:
18.17
52-Week Low:
10.75
Prediction Charts
Market Cap:
611.56M
Price in USD:
16.44
Volume:
142.81K
Beta:
-0.25
Technical Analysis
SMA50:
15.65
SMA100:
15.59
SMA200:
14.78
52-Wk Change:
7.52%
Stock Predictions
-
Is Entrada Therapeutics stock public?
Yes, Entrada Therapeutics is a publicly traded company. -
What is the Entrada Therapeutics stock quote today?
The Entrada Therapeutics stock price is 16.44 USD today. -
How to buy Entrada Therapeutics stock online?
You can buy Entrada Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Sep-16 | 15.06 | 14.55 | 15.42 | 14.50 |
| Sep-17 | 14.55 | 14.16 | 14.58 | 13.90 |
| Sep-18 | 14.13 | 13.66 | 14.26 | 13.46 |
| Sep-19 | 14.13 | 15.00 | 15.38 | 14.09 |
| Sep-20 | 14.84 | 14.69 | 15.09 | 14.55 |
| Sep-23 | 14.84 | 14.57 | 14.90 | 14.48 |
| Sep-24 | 14.66 | 15.41 | 15.44 | 14.49 |
| Sep-25 | 15.38 | 15.05 | 15.50 | 15.00 |
| Sep-26 | 15.41 | 15.78 | 16.16 | 15.11 |
| Sep-27 | 16.03 | 16.45 | 17.38 | 15.87 |
| Sep-30 | 16.30 | 15.98 | 16.66 | 15.59 |
| Oct-1 | 15.91 | 16.01 | 16.02 | 15.19 |
| Oct-2 | 16.03 | 16.30 | 16.42 | 15.53 |
| Oct-3 | 16.14 | 16.44 | 16.71 | 15.98 |
Entrada Therapeutics Earnings
Entrada Therapeutics Earnings Report: Per Share Entrada Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Entrada Therapeutics Forecast Revenue Growth
Entrada Therapeutics Stock Analysis: Historical quarterly revenues per share for Entrada Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $3.79 per share.
* Entrada Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.